Is a complete LON/0HRS research report available?

No complete published report is available for lon/0HRS (LON/0HRS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

lon/0HRS stock profile: metrics, valuation and analysis

Market cap	90.1B
Revenue (ttm)	311B
Net income (ttm)	3.7B
EPS (ttm)	$2.88
P/E (trailing)	24.4x
P/E (forward)	11.6x
Dividend	$2.00 (2.87%)
Volume	823
Beta	0.60

All LON/0HRS indicators

Market & fundamental data

Available fields

242

Groups with data

Currency

USD

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	300,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	$136.3B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Healthcare Plans
Isin	US1266501006
Last refreshed	2026-09-12
Market cap	$90.1B
Price	$94.28
Price currency	USD
Rev Per Employee	1,198,499.18x
Sector	Healthcare
Sector PE	20.64
Sector PE Fwd	13.38
Sic	8000
Symbol	lon/0HRS
Website	https://www.cvshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.09%
EV Earnings	36.99x
EV/EBIT	15.17x
EV/EBITDA	9.37x
EV/FCF	15.38x
EV/Sales	0.45x
FCF yield	9.84%
Forward P/E	11.62x
P/B ratio	1.5x
P/E ratio	24.44x
P/S ratio	0.29x
PE Ratio10 Y	23.26x
PE Ratio3 Y	35.75x
PE Ratio5 Y	30.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.95%
EBITDA Margin	4.04%
FCF margin	2.9%
Gross margin	13.64%
Gross Profit	$42.4B
Gross Profit Growth	10.11%
Gross Profit Growth Q	15.28%
Gross Profit Growth3 Y	1.97%
Gross Profit Growth5 Y	3.1%
Net Income	$3.7B
Net Income Growth	7.92%
Net Income Growth Q	191.77%
Net Income Growth Qo Q	1.22%
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Net Income Growth3 Y	18.15%
Net Income Growth5 Y	-7.45%
Pretax Margin	1.4%
Profit Margin	1.19%
Profit Per Employee	$14,203
Profitable Quarters	$3
Profitable Years	7
ROA	2.97
Roa5y	3.25
ROCE	7.29
ROE	6.21
Roe5y	7.3
ROIC	7.17
Roic5y	6.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	32.41%
Cagr3y	17.27%
Cagr5y	5.72%
Div CAGR3	4%
Div CAGR5	5.87%
EPS Growth	6.3
EPS Growth Q	188.8
EPS Growth Qo Q	0.43
EPS Growth Quarters	3
EPS Growth Years	0
EPS Growth3 Y	18.83
EPS Growth5 Y	-6.92
FCF Growth	145.98%
FCF Growth Q	338.3%
FCF Growth Qo Q	66.29%
FCF Growth3 Y	-12.7%
FCF Growth5 Y	0.24%
OCF Growth	95.3%
OCF Growth Q	234.48%
OCF Growth Qo Q	49.33%
OCF Growth10 Y	4.54%
OCF Growth3 Y	-10.36%
OCF Growth5 Y	0.83%
Revenue Growth	7.37x
Revenue Growth Q	7.14x
Revenue Growth Qo Q	5.61x
Revenue Growth Quarters	51x
Revenue Growth Years	13x
Revenue Growth3 Y	6.87x
Revenue Growth5 Y	8.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.61
Assets	$191.3B
Cash	$10.5B
Current Assets	$55.7B
Current Liabilities	$64.4B
Debt	$57.5B
Debt EBITDA	$3.87
Debt Equity	$0.96
Debt FCF	$6.49
Equity	$60.2B
Interest Coverage	3.92
Liabilities	$131B
Long Term Assets	$135.6B
Long Term Liabilities	$66.7B
Net Cash	$-47B
Net Cash By Market Cap	$-52.16
Net Debt EBITDA	$3.74
Net Debt Equity	$0.78
Net Debt FCF	$5.3
Tangible Book Value	$-22.9B
Tangible Book Value Per Share	$-17.94
WACC	5.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Inventory Turnover	20.32
Net Working Capital	$-16.4B
Quick ratio	0.62
Working Capital	$-8.8B
Working Capital Turnover	$-20.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.19%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	$2
Dividend Years	9
Dividend Yield	2.87%
Ex Div Date	2026-07-23
Last Dividend	$0.67
Payout Frequency	Quarterly
Payout Ratio	69.58%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	32.38%
200-day SMA	86.93
3Y total return	61.31%
50-day SMA	100.2
50-day SMA vs 200-day SMA	50over200
5Y total return	32.04%
All Time High	112
All Time High Change	-15.74%
All Time High Date	2026-08-05
All Time Low	43.56
All Time Low Change	116.67%
All Time Low Date	2024-12-23
ATR	3.36
Beta	0.6
Ch YTD	18.27
High	96.85
High52	112
High52 Date	2026-08-05
High52ch	-15.82%
Low	94.02
Low52	69.18
Low52 Date	2026-03-27
Low52ch	36.28%
Ma50ch	-5.79%
Price vs 200-day SMA	8.56%
RSI	41.2
RSI Monthly	59.61
RSI Weekly	52.96
Sharpe ratio	1.02x
Sharpe Ratio3y	0.52x
Sharpe Ratio5y	0.21x
Sortino ratio	1.61
Sortino Ratio3y	0.92
Sortino Ratio5y	0.48
Total Return	1.65%
Tr YTD	21.02
Tr1m	-1.07%
Tr1w	-3.11%
Tr3m	-2.67%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,276,459,455%
Net Borrowing	-3,863,568,775
Shares Insiders	0.09%
Shares Institutions	90.64%
Shares Qo Q	0.63%
Shares Yo Y	1.19%
Short Ratio	2.35

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$8.3B
Adjusted OCF	10,600,790,500
Average Volume	5,518.4x
Bv Per Share	47
CAPEX	$-2.3B
Ch1m	-1.07
Ch1w	-3.11
Ch1y	28.33
Ch3m	-3.26
Ch3y	43.95
Ch5y	11.93
Ch6m	22.53
Change	-1.16%
Change From Open	-2.51
Close	95.39
Days Gap	1.38
Depreciation Amortization	3,343,743,158
Dollar Volume	77,592.4
Earnings Date	2026-11-04
EBIT	$9.2B
EBITDA	$12.6B
EPS	$2.88
F Score	7
FCF	$8.9B
FCF EV Yield	6.5x
Financing CF	-6,349,922,500
Fiscal Year End	December
Founded	1,963
Goodwill	63,205,766,842
Graham Number	73.95351
Graham Upside	-21.56
Income Tax	$679.8M
Investing CF	-5,157,569,100
Is Primary Listing	0
Last Earnings Date	2026-08-05
Last Report Date	2026-06-30
Lynch Fair Value	$19.29
Lynch Upside	-79.54
Ma150	89.71
Ma150ch	5.19%
Ma20	94.98
Ma20ch	-0.64%
Net CF	-367,805,600
Next Earnings Date	2026-11-04
Open	96.71
P FCF Ratio	10.17
P FCF Ratio SBC	10.82
P OCF Ratio	8.09
P OCF Ratio SBC	8.5
Payment Date	2026-08-03
Position In Range	9.19
Ppne	20,422,565,741
Price Date	2026-09-11
Price EBITDA	$7.17
Relative Volume	0.15x
Revenue	311,010,536,500x
SBC By Revenue	0.17x
Share Based Comp	538,895,500
Tax By Revenue	0.22x
Tax Rate	15.59%
Tr6m	24.35%
Volume	823
Z Score	2.43

LON/0HRS (LON/0HRS)

Price

Financial snapshot

Fair-value bridge

Latest news · LON/0HRS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LON/0HRS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on LON/0HRS

Frequently asked questions